Orhan Sezer

29.5k total citations · 1 hit paper
171 papers, 11.0k citations indexed

About

Orhan Sezer is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Orhan Sezer has authored 171 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Oncology, 76 papers in Molecular Biology and 73 papers in Hematology. Recurrent topics in Orhan Sezer's work include Multiple Myeloma Research and Treatments (72 papers), Bone health and treatments (32 papers) and Peptidase Inhibition and Analysis (31 papers). Orhan Sezer is often cited by papers focused on Multiple Myeloma Research and Treatments (72 papers), Bone health and treatments (32 papers) and Peptidase Inhibition and Analysis (31 papers). Orhan Sezer collaborates with scholars based in Germany, United Kingdom and United States. Orhan Sezer's co-authors include Ulrike Heider, Christian Jakob, Ivana Zavrski, Kurt Possinger, Martin Kaiser, Jan Eucker, Claudia Fleissner, Jane Blazeby, Evangelos Terpos and Thierry Conroy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Orhan Sezer

165 papers receiving 10.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

2005 992 citations Giampaolo Merlini, Philippe Moreau et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Orhan Sezer	5.2k	4.6k	3.9k	1.7k	1.2k	171	11.0k
Stanley Cohen	3.9k 0.7×	3.2k 0.7×	4.7k 1.2×	1.0k 0.6×	537 0.4×	214	18.4k
Efstathios Kastritis	5.7k 1.1×	6.8k 1.5×	5.5k 1.4×	999 0.6×	797 0.7×	583	15.0k
Seema Singhal	4.0k 0.8×	4.6k 1.0×	7.0k 1.8×	477 0.3×	545 0.5×	291	10.7k
Ben A. C. Dijkmans	1.9k 0.4×	2.8k 0.6×	6.1k 1.6×	1.6k 1.0×	991 0.8×	332	25.0k
James L.M. Ferrara	3.4k 0.7×	2.7k 0.6×	11.9k 3.1×	1.3k 0.8×	1.4k 1.1×	270	18.6k
Magnus Björkholm	4.0k 0.8×	5.0k 1.1×	5.6k 1.5×	1.1k 0.6×	1.1k 0.9×	488	16.3k
Ingrid Pabinger	2.3k 0.4×	1.8k 0.4×	10.5k 2.7×	2.5k 1.5×	1.6k 1.3×	541	20.3k
Jerome B. Zeldis	5.5k 1.1×	7.8k 1.7×	10.1k 2.6×	682 0.4×	613 0.5×	202	15.4k
Ronald S. Go	2.5k 0.5×	1.8k 0.4×	2.0k 0.5×	660 0.4×	752 0.6×	362	7.3k
Cihan Ay	2.3k 0.4×	1.2k 0.3×	3.5k 0.9×	2.0k 1.2×	1.3k 1.1×	384	12.8k

Countries citing papers authored by Orhan Sezer

Since Specialization

Citations

This map shows the geographic impact of Orhan Sezer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orhan Sezer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orhan Sezer more than expected).

Fields of papers citing papers by Orhan Sezer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orhan Sezer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orhan Sezer. The network helps show where Orhan Sezer may publish in the future.

Co-authorship network of co-authors of Orhan Sezer

This figure shows the co-authorship network connecting the top 25 collaborators of Orhan Sezer. A scholar is included among the top collaborators of Orhan Sezer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orhan Sezer. Orhan Sezer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caers, Jo, Bruno Paiva, Elena Zamagni, et al.. (2018). Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. Journal of Hematology & Oncology. 11(1). 10–10. 152 indexed citations

Donk, Niels W.C.J. van de, Antonio Palumbo, Hans Erik Johnsen, et al.. (2014). The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network. Haematologica. 99(6). 984–996. 107 indexed citations

Hildebrandt, York, Yan Cao, C. Keller, et al.. (2012). Role of Interleukin 16 in Multiple Myeloma. JNCI Journal of the National Cancer Institute. 104(13). 1005–1020. 38 indexed citations

Arrarás, Juan Ignacio, Eva Greimel, Wei‐Chu Chie, et al.. (2011). Information disclosure to cancer patients: EORTC QLQ-INFO25 questionnaire. Expert Review of Pharmacoeconomics & Outcomes Research. 11(3). 281–286. 10 indexed citations

Terpos, Evangelos, Meletios Α. Dimopoulos, Orhan Sezer, et al.. (2010). The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group. Leukemia. 24(10). 1700–1712. 65 indexed citations

Engert, Andreas, Volker Diehl, Jeremy Franklin, et al.. (2009). Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study. Journal of Clinical Oncology. 27(27). 4548–4554. 303 indexed citations

Heider, Ulrike, Jessica Rademacher, Britta Lamottke, et al.. (2009). Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma. European Journal Of Haematology. 82(6). 440–449. 141 indexed citations

Harris, Kristin, Edward Chow, Liying Zhang, et al.. (2009). Patients’ and health care professionals’ evaluation of health-related quality of life issues in bone metastases. European Journal of Cancer. 45(14). 2510–2518. 44 indexed citations

Dimopoulos, Meletios Α., Evangelos Terpos, Raymond L. Comenzo, et al.. (2009). International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia. 23(9). 1545–1556. 324 indexed citations

10.

Metzler, Ivana von, Ulrike Heider, Maren Mieth, et al.. (2009). Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma. Experimental Cell Research. 315(14). 2471–2478. 10 indexed citations

11.

Beinert, T., H.‐G. Mergenthaler, Orhan Sezer, et al.. (2008). Hypoxie bei soliden Tumoren. DMW - Deutsche Medizinische Wochenschrift. 124(17). 534–540.

12.

Röcken, Christoph, Jochen Ernst, Ernst Hund, et al.. (2006). Interdisziplinäre Leitlinien zur Diagnostik und Therapie der extrazerebralen Amyloidosen: Herausgegeben von der Deutschen Gesellschaft für Amyloid-Krankheiten e. V. (www.amyloid.de). Medizinische Klinik - Intensivmedizin und Notfallmedizin. 101(10). 825–829.

13.

Thomas, Anke, Jens‐Uwe Blohmer, Orhan Sezer, et al.. (2006). Peripheral Neuroectodermal Tumor (PNET) of the Breast – a 6-Year Follow-Up. Breast Care. 1(5). 324–327. 6 indexed citations

14.

Schmid, Peter, Bernd Flath, V. Heilmann, et al.. (2005). Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study. Investigational New Drugs. 23(4). 349–356. 4 indexed citations

15.

Jakob, Christian, Ivana Zavrski, Ulrike Heider, et al.. (2003). Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiography.. PubMed. 9(8). 3047–51. 26 indexed citations

16.

Niemöller, Kathrin, Christian Jakob, Ulrike Heider, et al.. (2003). Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III. Journal of Cancer Research and Clinical Oncology. 129(4). 234–238. 27 indexed citations

17.

Sezer, Orhan, Kathrin Niemöller, Christian Jakob, et al.. (2001). Relationship between bone marrow angiogenesis and plasma cell infiltration and serum β2-microglobulin levels in patients with multiple myeloma. Annals of Hematology. 80(10). 598–601. 36 indexed citations

18.

Vickery, C W, Jane Blazeby, Thierry Conroy, et al.. (2001). Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. European Journal of Cancer. 37(8). 966–971. 149 indexed citations

19.

Eucker, Jan, Orhan Sezer, R. Lehmann, et al.. (2000). Disseminated Mucormycosis Caused by Absidia corymbifera Leading to Cerebral Vasculitis. Infection. 28(4). 246–250. 31 indexed citations

20.

Sezer, Orhan, Peter Schmid, Michael Schweigert, et al.. (1999). Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support. Bone Marrow Transplantation. 23(9). 967–969. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact